bhu.pngbhu.png

Axcer 90mg Tablet

Introduction

Axcer 90mg Tablet 14s is utilized to prevent heart attacks, strokes, or deaths in individuals who have experienced heart attacks or acute coronary syndrome Additionally, it's used to prevent blood clot formation in patients with coronary stents to manage ACS.

It belongs to a group of drugs known as antiplatelet medications It functions by stopping platelets (a specific type of blood cell) from gathering and creating clots that could lead to a heart attack or stroke.

Continue taking Ticagrelor regularly as prescribed by your doctor, even if you feel fine, to prevent heart and blood vessel issues Avoid stopping Ticagrelor abruptly without consulting your doctor, as it might increase the risk of heart attack, stroke, or blood clots in stents.

Patients prescribed it should adhere to their healthcare provider's recommendations regarding dosage and duration of treatment.

It is crucial to report any persistent symptoms or adverse effects promptly.

How it works

Ticagrelor (90mg) is an antiplatelet medication that inhibits the P2Y12 receptor, preventing ADP-mediated platelet activation. This action reduces platelet aggregation, lowering the risk of blood clot formation. Widely used in preventing cardiovascular events, Ticagrelor provides antiplatelet effects without requiring metabolic activation, making it a valuable option in managing acute coronary syndromes and reducing the incidence of thrombotic events.

How to take

["Follow your doctor's prescribed dose and duration.\n","Avoid chewing, crushing, or breaking it.\n","It can be taken with or without food, but adherence to a fixed time is preferable.\n","Strictly adhere to the prescribed regimen for optimal effectiveness.\n"]

Adverse drug effect

It may cause side effects like bleeding, bruising, dizziness, skin rash, blurred vision, and increased uric acid levels. Most side effects are mild and temporary. Consult your doctor if symptoms persist or worsen. Avoid concomitant use of ticagrelor with other blood-thinning agents to prevent excessive bleeding.

@2024 BHU Banaras Hindu University